Beauty Health (NASDAQ:SKIN), Inc. (NASDAQ: SKIN) is a medical aesthetics company best known for its HydraFacial® treatment platform. The company designs, manufactures and commercializes skincare devices and consumables that deliver a multi-step facial therapy combining cleansing, exfoliation, extraction, hydration and antioxidant protection. Beauty Health supports a broad network of physician practices, dermatology clinics, medical spas and wellness centers through direct sales and distribution partnerships.
Beauty Health’s product portfolio centers on the patented Vortex-Fusion® technology underlying HydraFacial, which has been adapted into multiple device models and specialized treatment protocols. In addition to core consumable serums and booster solutions, the company offers turnkey training programs, marketing support and digital tools that help provider partners optimize patient engagement and retention. Beauty Health continues to expand its offerings with advanced treatments targeting scalp health and skin rejuvenation, as well as research and development initiatives focused on next-generation applicators and formulations.
Founded in the late 1990s with the launch of HydraFacial, the company evolved through successive product enhancements and international geographic expansion. Today, Beauty Health is headquartered in Dallas, Texas, and maintains regional offices across North America, Europe, Asia and Latin America. Its executive leadership team brings decades of combined experience in dermatology, medical device development and global business operations, underscoring the company’s commitment to innovation and service excellence.
Looking ahead, Beauty Health aims to drive growth through continued product innovation, expanded global distribution and enhanced digital engagement. The company’s strategy emphasizes sustainable revenue streams through recurring consumable sales, robust training and certification offerings, and strategic alliances with leading aesthetic practitioners worldwide.
